Matinas BioPharma Holdings (MTNB) Free Cash Flow Growth (1y) (2014 - 2026)
Matinas BioPharma Holdings (MTNB) Free Cash Flow Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 60.84% |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 88.70% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -15.72% |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 66.37% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Matinas BioPharma Holdings | 4.60 Mn | 2.15 Mn | - | 20.23% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.23% |
| Dec 31, 2025 | 57.01% |
| Sep 30, 2025 | 57.89% |
| Jun 30, 2025 | 34.93% |
| Mar 31, 2025 | 65.21% |
| Dec 31, 2024 | 23.35% |
| Sep 30, 2024 | 21.08% |
| Jun 30, 2024 | -41.63% |
| Mar 31, 2024 | -41.15% |
| Dec 31, 2023 | -5.48% |
| Sep 30, 2023 | 15.04% |
| Jun 30, 2023 | 57.71% |
| Mar 31, 2023 | 22.90% |
| Dec 31, 2022 | -8.71% |
| Sep 30, 2022 | 9.22% |
| Jun 30, 2022 | -499.78% |
| Mar 31, 2022 | -13.97% |
| Dec 31, 2021 | 7.30% |
| Sep 30, 2021 | -10.01% |
| Jun 30, 2021 | 72.71% |